Skip to main content
TipRanks
Go Ultimate75% OFF

Helix BioPharma (HBP) Income Statement

32 Followers

Helix BioPharma Income Statement

Last quarter (Q4 2026), Helix BioPharma's total revenue was C$0.00. In Q4, Helix BioPharma's net income was C$-980.00K. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJul 26Jul 25Jul 24Jul 23Oct 22
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
C$ -4.00KC$ -10.00KC$ -14.00KC$ -13.00KC$ -12.00K
C$ 3.64MC$ 5.42MC$ 9.36MC$ 6.33MC$ 6.04M
Depreciation and AmortizationC$ 4.00KC$ 10.00KC$ 14.00KC$ 13.00KC$ 12.00K
C$ -3.65MC$ -5.21MC$ -9.38MC$ -6.31MC$ -6.03M
C$ -3.64MC$ -5.42MC$ -9.37MC$ -6.28MC$ -6.54M
C$ 285.00KC$ 192.00KC$ -25.00KC$ 36.00KC$ -523.00K
C$ -3.35MC$ -5.23MC$ -9.40MC$ -6.29MC$ -6.56M
C$ -3.35MC$ -5.21MC$ -9.26MC$ -6.29MC$ -6.08M
Per Share Metrics
Basic EPSC$ -0.04C$ -0.09C$ -0.21C$ -0.16C$ -0.20
Diluted EPSC$ -0.04C$ -0.09C$ -0.21C$ -0.16C$ -0.20
Weighted Average Shares Outstanding76.25M55.74M44.49M38.65M29.90M
Weighted Average Shares Outstanding (Diluted)76.25M55.74M44.49M38.65M29.90M

Currency in CAD

Helix BioPharma Earnings and Revenue History

-12M-8M-4M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin